Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Clint Carnell
AddedMar 31, 2024
UpdatedMay 31, 2026
Clint Carnell

Clint Carnell

Board Member, Orange Twist

CrunchbaseLinkedIn

Clint Carnell's Career

Orange Twist
Orange Twist

Costa Mesa, CA, US

Board Member· Board
Sente
Sente

Carlsbad, CA, US

Board Member· Board
Inbrace
Inbrace

Irvine, CA, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Clint Carnell's Career

Orange Twist
Orange Twist
Seed$189.9k1752015Costa Mesa, CA, US
Board Member· Board

Leadership at Orange Twist

Paul GainerPaul GainerCEO
Grant Stevens, MDGrant Stevens, MDFounder

Similar to Orange Twist

Ever/BodyEver/BodyNew York City, NY, USCosmetic Dermatologyest. 2018Ever/BodyNew York City, NY, US · est. 2018

Expert cosmetic dermatology provider offering medically tested, curated products with minimal downtime.

Series C · $110.5M165
Persimmon.LifePersimmon.LifeLarkspur, CA, USAesthetic Treatmentsest. 2021Persimmon.LifeLarkspur, CA, US · est. 2021

Persimmon: Revolutionizing in-home aesthetic treatments via telehealth, empowering nurses and enhancing well-being.

Series A · $5.3M68
Alchemy 43Alchemy 43Beverly Hills, CA, USCosmetic Treatmentsest. 2014Alchemy 43Beverly Hills, CA, US · est. 2014

Alchemy 43: High-quality cosmetic injectable treatments in a premium clinic setting.

Seed · $3.2M41
OluraOluraFranklin, TN, USBeauty Devicesest. 2016OluraFranklin, TN, US · est. 2016

OLURA: Providing clinical-grade beauty devices for astonishing at-home results.

Angel · $200k30
Sente
Sente
Series A$17.9M492007Carlsbad, CA, US
Board Member· Board

Leadership at Sente

Laurent CombredetLaurent CombredetCEO
Kleanthis G. XanthopoulosKleanthis G. XanthopoulosBoard Member
Faheem HasnainFaheem HasnainBoard Member
Magda MarquetMagda MarquetBoard Member

Similar to Sente

Enhance Skin ProductsEnhance Skin ProductsDenver, CO, USCosmetics, Skincareest. 2006Enhance Skin ProductsDenver, CO, US · est. 2006

Enhance Skin Products, Inc.: Premium provider of branded cosmeceuticals that biologically enhance skin.

Public6
StratiaStratiaBoston, MA, USCosmetics, Skincareest. 2016StratiaBoston, MA, US · est. 2016

Stratia: Your online destination for premium skincare products.

Seed · $2M8
CurologyCurologySan Francisco, CA, USSkincareest. 2014CurologySan Francisco, CA, US · est. 2014

Curology offers personalized prescription skincare, targeting acne and anti-aging, delivered to your door.

Series B · $19.1M750
FutureDermFutureDermPittsburgh, PA, USProducts, Skincareest. 2012FutureDermPittsburgh, PA, US · est. 2012

FutureDerm: Your global online hub for science-backed skincare insights and products.

Angel · $682.8k5
Inbrace
Inbrace
Series D$217.6M1902014Irvine, CA, US
CEO· C-Suite · Management

Leadership at Inbrace

John PhamJohn PhamFounder

People Similar to Clint Carnell

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoJiarui LiJiarui LiCEO · InnatrixMark WestermanMark WestermanCEO · Intrinsic LifeSciencesDebra S. LandersDebra S. LandersCEO · BriyeLaurie PetersonLaurie PetersonCEO · Build & ImagineScott AlbertScott AlbertBoard Member · EasyVote SolutionsKeith CarlsonKeith CarlsonBoard Member · Wildnote